<DOC>
	<DOCNO>NCT00656565</DOCNO>
	<brief_summary>Adequate administration drug via dry powder inhaler dependent adequate inspiratory flow rate volumes . These vary accord device use resistance . The dry powder inhaler device investigation device approve Therapeutic Goods Administration ( ARTG . 196255 ) use dry powder mannitol . Dry powder mannitol currently investigate treatment bronchiectasis . We wish measure inspiratory flow characteristic low high resistance device amongst group subject bronchiectasis . We propose majority subject investigate vary lung function achieve adequate flow control inspiration .</brief_summary>
	<brief_title>Inspiratory Flow Volumes Bronchiectatics</brief_title>
	<detailed_description />
	<mesh_term>Respiratory Aspiration</mesh_term>
	<mesh_term>Bronchiectasis</mesh_term>
	<criteria>noncf bronchiectasis age 1880 inclusive FEV1 great equal 50 % predict great equal 1L uncontrolled asthma CF bronchiectasis condition spirometry measurement would contraindicate</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2008</verification_date>
	<keyword>measure inspiratory spirometry dry powder inhaler device series spirometer</keyword>
</DOC>